Feature

Universal vs Risk-Based Screening in Pregnancy: An Expert Weighs In

There is a lack of consensus among experts and professional organizations whether HCV screening in pregnant women should be risk based or universal.

How Often Should We Test for Hepatitis C in People Who Inject Drugs?

A major challenge associated with hepatitis screening is the loss to follow-up that occurs in people who inject drugs.

Toward Integrated Care for Hepatitis C Infection and Addiction

There is an opportunity to improve HCV treatment rates for people who inject drugs by integrating DAA therapy into current models of community-based addiction.

Clinical Significance of the Isolated Anti-HBc Serologic Pattern

A serological pattern called isolated anti-HBc, characterized by the presence of hepatitis B core antibody (anti-HBc) and the absence of hepatitis B surface antigen and ...

Point-Counterpoint: Should We Implement Needle Exchange Programs for the Prevention of Hepatitis C Virus?

Of the approximately 12.7 to 16 million people who inject drugs (PWID) worldwide, an estimated 10 million individuals have hepatitis C virus (HCV), making it ...

Can Direct-Acting Antivirals Finally Achieve Hepatitis C Elimination?

Unrestricted use of DAAs may be an invaluable component of preventing HCV transmission by reducing the infectious pool of individuals.

Etiology of Acute Liver Failure Can Yield Surprising Findings

Before the advent of potent antiviral agents, liver transplantation was the only treatment option for patients with hepatitis and a poor prognosis; antiretrovirals can now ...

Addressing Palliative Care in Hepatocellular Carcinoma

Research shows that palliative care can help with symptom management, care coordination, therapeutic decision making, and the psychosocial aspects of living with hepatocellular carcinoma.

News Articles

A New Nucleotide Analog Is Well Tolerated, Efficacious Against HCV Genotype 1-4

A New Nucleotide Analog Is Well Tolerated, Efficacious Against HCV Genotype 1-4

A new nucleotide analog is a pangenotypic HCV nonstructural protein 5B inhibitor that is well tolerated when administered in single and multiple doses.

Low Rates of HBsAg Seroclearance in Chronic HBV Infection

Low Rates of HBsAg Seroclearance in Chronic HBV Infection

Low rates of HBsAg seroclearance were found in untreated and treated patients with chronic hepatitis B infection.

High Prevalence of Cirrhosis in Adults With Chronic HBV at a Safety-Net Hospital

High Prevalence of Cirrhosis in Adults With Chronic HBV at a Safety-Net Hospital

Investigators aimed to determine rates and predictors of cirrhosis and cirrhosis-related complications in patients with chronic hepatitis B infection.

Economic Comparison of Screening Strategies for Hepatitis C Virus

Economic Comparison of Screening Strategies for Hepatitis C Virus

Investigators examined the cost of screening for HCV utilizing 2 methods, ELISA followed by PCR and PCR alone.

Journal Articles

Sign Up for Free e-newsletters